CGT

48개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved48 programs
CGTLimited DatastaleRobbie MajznerPhase 1

B7-H3.CD28Z.CART (B7-H3.CD28Z.CART)

Central Nervous System Neoplasms; Brain Tumor · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleStanford UniversityPhase 1

GPC2-CAR T cells (GPC2-CAR T cells)

Medulloblastoma; Central Nervous System Embryonal Tumor · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleShanghai Xiniao Biotech Co., Lt…Phase 1

UCAR T-cell group (UCAR T-cell group)

Systemic Lupus Erythematosus · Myasthenia Gravis

#MyastheniaGravis#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

ALTCAR.CD30 cells (ALTCAR.CD30 cells)

Lymphoma; Immune System Diseases · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

ATLCAR.CD30.CCR4 cells (ATLCAR.CD30.CCR4 cells)

Lymphoma; Immune System Diseases · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Changzheng HospitalPreclinical

Anti-CD19-CD3E-CAR-T cells (Anti-CD19-CD3E-CAR-T cells)

Systemic Lupus Erythematosus (SLE); Sjogren's Syndrome · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleRegional Blood Center of Ribeir…Phase 2

Autologous CD19-Directed CAR-T Cells Manufactured at Ribeirão Preto Blood Center (Autologous CD19-Directed CAR-T Cells Manufactured at Ribeirão Preto Blood Center)

Lupus Erythematosus, Systemic · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastalePeking University People's Hosp…Phase 2

BCMA-CD19 CAR-T therapy (BCMA-CD19 CAR-T therapy)

Systemic Lupus Erythematosus; Inflammatory Myopathy · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleFondazione Policlinico Universi…Phase 2

CAR T cell (CAR T cell)

Lupus Erythematosus, Systemic; System; Sclerosis · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleMinsk scientific and practical …Preclinical

CAR T cells chimeric antigen receptor cells (CAR T cells chimeric antigen receptor cells)

System Lupus Erythematosus(SLE) · System Lupus Erythematosus(SLE)

#SystemLupusErythematosusSLE#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleGuangzhou Bio-gene Technology C…Phase 2

CD19 CAR-T cell infusion (CD19 CAR-T cell infusion)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

CD19 Universal CAR-T cells (CD19 Universal CAR-T cells)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleNanjing Bioheng Biotech Co., Lt…Phase 1

CD19 or CD19-BCMA CAR-T (CD19 or CD19-BCMA CAR-T)

SLE (Systemic Lupus); Systemic Sclerosis · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

CD19-BCMA CAR-T cells infusion (CD19-BCMA CAR-T cells infusion)

Refractory Lupus Nephritis; Systemic Sclerosis · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUnion Hospital, Tongji Medical …Phase 1

CD19/BCMA CAR-T cell therapy (CD19/BCMA CAR-T cell therapy)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

CD20-directed CAR-T cells with CliniMACS Prodigy® system (CD20-directed CAR-T cells with CliniMACS Prodigy® system)

B Cell Lymphoma · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleSeattle Children's HospitalPhase 1

EGFR806-specific chimeric antigen receptor (CAR, EGFR806-specific chimeric antigen receptor, EGFR806-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells (Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells)

Difficult to Treat Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

HER2-specific chimeric antigen receptor (CAR, HER2-specific chimeric antigen receptor, HER2-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · HER2

#HER2#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

SCRI-CAR19v3 (SCRI-CAR19v3)

Systemic Lupus Erythematosus · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting

2 / 3 pages

← PreviousNext →